Urine melatonin levels are inversely associated with sarcopenia in postmenopausal women

Menopause

Volumn 21, Issue 1, 2014, Pages 39-44

  Lee, Jee Yon ^a   Kim, Jung Ha ^b   Lee, Duk Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

6 Sulfatoxymelatonin; Melatonin; Sarcopenia

Indexed keywords

6 HYDROXYMELATONIN O SULFATE;

ADULT; ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; RISK FACTOR; SARCOPENIA; URINE LEVEL;

ABSORPTIOMETRY, PHOTON; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MELATONIN; MIDDLE AGED; POSTMENOPAUSE; REPUBLIC OF KOREA; SARCOPENIA;

EID: 84891826653     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e318291f6c8     Document Type: Article

References (44)

1. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr 2000;54:S40-S47.
2. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 2002;57:B359-B365.
3. Stephen W, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009;13:460-466.
4. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 2010;5:e10805.
5. Abe T, Thiebaud RS, Loenneke JP, Bemben MG, Loftin M, Fukunaga T. Influence of severe sarcopenia on cardiovascular risk factors in nonobese Men. Metab Syndr Relat Disord 2012;10:407-412.
6. Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr 2012;56:270-278
7. Drey M. SarcopeniaVpathophysiology and clinical relevance. Wien Med Wochenschr 2011;161:402-408.
8. Alway SE, Siu PM. Nuclear apoptosis contributes to sarcopenia. Exerc Sport Sci Rev 2008;36:51-57.
9. Marzetti E, Lees HA, Wohlgemuth SE, Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 2009;35:28-35.
10. Doria E, Buonocore D, Focarelli A, Marzatico F. Relationship between human aging muscle and oxidative system pathway. Oxid Med Cell Longevity 2012;2012:830257.
11. Tan D, Reiter R, Manchester L, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002;2:181-197.
12. Vakkuri O, Kivela A, Leppaluoto J, Valtonen M, Kauppila A. Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. Eur J Endocrinol 1996;135:188-192.
13. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Neuroendocrinology 2010;1:127-151.
14. Cardinali DP, Cano P, Jimenez-Ortega V, Esquifino AI. Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications. Neuroendocrinology 2011;93:133-142.
15. Carpentieri A, D?az de Barboza G, Areco V, Peralta Lopez M, Tolosa de Talamoni N. New perspectives in melatonin uses. Pharmacol Res 2012; 65:437-444.
16. Hirata H, Asanuma M, Cadet JL. Melatonin attenuates methamphetamineinduced toxic effects on dopamine and serotonin terminals in mouse brain. Synapse 1998;30:150-155.
17. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889-896.
18. Stratos I, Richter N, Rotter R, et al. Melatonin restores muscle regeneration and enhances muscle function after crush injury in rats. J Pineal Res 2011;52:62-70.
19. Kim CH, Kim KH, Yoo YM. Melatonin protects against apoptotic and autophagic cell death in C2C12 murine myoblast cells. J Pineal Res 2011;50:241-249.
20. Park S, Lee SK, Park K, et al. Beneficial effects of endogenous and exogenous melatonin on neural reconstruction and functional recovery in an animal model of spinal cord injury. J Pineal Res 2011;52:107-119.
21. Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010;33:1652-1654.
22. Kim YS, Lee Y, Chung YS, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 2012;67:1107-1113.
23. Ruiz-Ruiz J, Mesa JLM, Gutierrez A, Castillo MJ. Hand size influences optimal grip span in women but not in men. J Hand Surg 2002; 27:897-901.
24. Nowak R, McMillen IC, Redman J, Short R. The correlation between serum and salivary melatonin concentrations and urinary 6- hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol 1987;27: 445-452.
25. Lang U, Kornemark M, Aubert ML, Sizonenko PC. Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity. J Clin Endocrinol Metab 1981; 53:645-650.
26. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005;97:1084-1087.
27. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens 2010; 28:446.
28. Blaicher W, Speck E, Imhof MH, et al. Melatonin in postmenopausal females. Arch Gynecol Obstet 2000;263:116-118.
29. Basket JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 1998;24:58-61.
30. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 1998;24:230-238.
31. Fulle S, Fano G. The contribution of reactive oxygen species in sarcopenia and muscle aging. Role of Physical Exercise in Preventing Disease and Improving the Quality of Life. Milan: Springer. 2007:103-111.
32. ErkanlN K, Kayalar N, ErkanlN G, Ercan F, Sener G, KNrali K. Melatonin protects against ischemia/reperfusion injury in skeletal muscle. J Pineal Res 2005;39:238-242.
33. Hibaoui Y, Reutenauer-Patte J, Patthey-Vuadens O, Ruegg UT, Dorchies OM. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy. J Pineal Res 2011; 51:163-171.
34. Vingradova I, Iliukha V, Fedorova A, Khizhkin E, Unzhakov A, Iunash V. [Age-related changes of exercise capacity and some biochemical indices of rat muscles under influence of different light conditions and pineal preparations]. Adv Gerontol 2007;20:66-73.
35. Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010;80:1844-1852.
36. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and agerelated sarcopenia. Curr Opin Clin Nutr Metab Care 2012;15:12-22.
37. Schaap LA, Pluijm SMF, Deeg DJH, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;64:1183-1189.
38. Tidball JG. Interactions between muscle and the immune system during modified musculoskeletal loading. Clin Orthopaed Relat Res 2002;403: S100-S109.
39. Aleman H, Esparza J, Ramirez FA, Astiazaran H, Payette H. Longitudinal evidence on the association between interleukin-6 and C-reactive protein with the loss of total appendicular skeletal muscle in free-living older men and women. Age Ageing 2011;40:469-475.
40. Haren MT, Malmstrom TK, Miller DK, et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 2010; 65:274-281.
41. Cheung KMC, Wang T, Hu Y, Leong JCY. Primary thoracolumbar scoliosis in pinealectomized chickens. Spine 2003;28:2499-2504.
42. Machida M, Murai I, Miyashita Y, Dubousset J, Yamada T, Kimura J. Pathogenesis of idiopathic scoliosis: experimental study in rats. Spine 1999;24:1985-1989.
43. Machida M, Dubousset J, Imamura Y, Iwaya T, Yamada T, Kimura J. Role of melatonin deficiency in the development of scoliosis in pinealectomised chickens. J BoneJoint Surg Br 1995;77:134-138.
44. Wan Q, Pang SF. Segmental, coronal and subcellular distribution of 2-[125I]iodomelatonin binding sites in the chicken spinal cord. Neurosci Lett 1994;180:253-256.